welcome to oneEDSvoice
- a positively charged Ehlers Danlos Syndrome community.- join today!
- login
scientific articles
The Successful Use of Recombinant Factor VIIa in a Patient with Vascular-Type Ehlers-Danlos Syndrome
source: Acta Anaesthesiologica Scandinavica
year: 2007
authors: Faber P, Craig WL, Duncan JL, Holliday K
summary/abstract:Vascular-type Ehlers-Danlos syndrome is an inherited connective tissue disorder resulting in an increased risk of serious peri-operative bleeding during surgery for spontaneous organ or vessel rupture. The excessive bleeding may result in coagulopathy, and thus compound the difficulty in securing surgical haemostasis. With the advent of recombinant factor VIIa, a new therapy has become available for the management of intractable surgical bleeding.
organization: Aberdeen Royal InfirmaryDOI: 10.1111/j.1399-6576.2007.01416.x
read more full text source
expertly curated content related to this topic
-
An Exon Skipping Mutation of a Type V Collagen Gene (COL5A1) in Ehlers-Danlos SyndromeThe Ehlers-Danlos syndrome (EDS) is a he...
-
Classifications of EDS: Hypermobility Typehttps://www.youtube.com/watch?v=nSO1Sut1...
-
Type III Collagen Regulates Osteoblastogenesis and the Quantity of Trabecular BoneType III collagen (Col3), a fibril-formi...
-
Delia Chiaramonte, MDDelia Chiaramonte, M.D. is an integrati...
-
Ronald K. Jaekle, MDDr. Ronald Jaekle is an obstetrician-gyn...
-
Ehlers Danlos Treatment and Social Support GroupThere is an extreme lack of awareness in...
-
In the FringesEhlers-Danlos Syndrome is a motley group...
